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Indeed, several biological pathways alter the inflammatory 
response to infectious agents. One of the recently recognized path-
ways is autophagy. Dr. Munz elegantly described how autophagy 
modulates inflammation and infection. He also provided infor-
mation on how the inflammasome controls autophagy. On the 
other hand, microbe-focused reviews convince us that the pathogen 
ironically manipulates, exploits and evade recognition, and innate 
immune response by extraordinary tactics. Some organisms sur-
vive inside or outside enclosing vacuoles within eukaryotic cells 
such as Listeria reviewed by Dr. Opitz. He focused his review on 
the ability of this organism to differentially coordinate immune 
responses whether inside or outside an enclosing vacuole. Bacteria 
with increasing tendency to linger within enclosed vacuoles such 
as Salmonella, possess a plethora of virulence factors employed to 
modulate the innate immune response and inflammation is reviewed 
by Dr. Franchi. Surprisingly, vacuole-residing organisms such as 
Mycobacteria still modulate the inflammatory responses beyond 
its well protected vacuole. Dr. Torrelles describes in details how 
Mycobacteria perform this task. Dr. Gavrilin draws our attention 
to the important differences in innate immune responses between 
human and mice in response to Francisella. The review by Dr. Amer 
on why humans are susceptible to Legionella while mice are resist-
ant further emphasizes this notion. This issue is embellished with 
two original research articles describing new findings in Legionella 
pathogenesis by Zamboni and Amer groups. Hope when the reader 
reaches the end of this issue, he or she will be fascinated with the 
interplay between the inflammasome and the pathogen.
Received: 11 January 2011; accepted: 11 January 2011; published online: 26 January 
2011.
Citation: Amer AO (2011) The inflammasome. Front. Microbio. 2:4. doi: 10.3389/
fmicb.2011.00004
This article was submitted to Frontiers in Cellular and Infection Microbiology, a specialty 
of Frontiers in Microbiology.
Copyright © 2011 Amer. This is an open-access article subject to an exclusive license agreement 
between the authors and Frontiers Media SA, which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original authors and source are credited.
There is a clear need for interdisciplinary research and publica-
tions that bring together scientists who work on the inflamma-
some. This protein complex, termed the inflammasome and many 
of its components are implicated in disease disorders, autoimmune, 
and infectious diseases. The structure, activation, and regulation 
of the inflammasome complex have been and are still studied in 
increasing number of laboratories around the world. Our goal is to 
provide an issue summarizing every fascinating aspect of inflamma-
some activation and modulation of the innate immune response to 
microbial and to danger signals. This issue will bring the experts in 
inflammasome research up to speed with the most recent findings. 
However, several reviews are geared toward introducing the new 
scientists to the inflammasome complex and to the fundamental 
and essential information that will help them understand and even 
pursue their studies in this direction. By looking at the two sides 
of the coin, notably, some authors focused on the inflammasome 
as a major participant in innate immunity and tackled the infec-
tious agents as modulators. Other authors considered the organ-
ism as the major player in the infected cell, while considering the 
inflammasome a contributor to immune response and to the fate 
of the pathogen.
The basics of the inflammasome and its essential functions in 
the cell are reviewed in details by Dr. Lamkanfi. As an expert in cas-
pases and their activation, Dr. Lamkanfi presented the fundamental 
information regarding the composition and the activation of the 
inflammasome. He then supplied a nice overview on how bacterial 
and viral pathogens prevent the activation of the inflammasome, 
in most cases to their advantage. Dr. Saleh’s review explored deeper 
aspects of the inflammasome during bacterial, viral, fungal, para-
sitic, and fungal infections. She provided a detailed description of 
how pathogens interact with the inflammasome, avoid, or suppress 
it. Then, Dr. Kanneganti polishes our knowledge about the inflam-
masome with her expert opinion on the major molecules involved 
in the modulation of the inflammasome and on human diseases 
impacted by the inflammasome.
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